4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D001711:Biotransformation; D002273:Carcinogens / Q000032:analysis / Q000378:metabolism / Q000633:toxicity*; D055598:Chemical Phenomena; D002621:Chemistry; D006224:Cricetinae; D005260:Female; D006801:Humans; D008297:Male; D008647:Mesocricetus; D051379:Mice; D008810:Mice, Inbred C57BL; D009152:Mutagenicity Tests; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009602:Nitrosamines / Q000032:analysis / Q000378:metabolism / Q000633:toxicity*; D010947:Plants, Toxic; D011247:Pregnancy; D051381:Rats; D011916:Rats, Inbred F344; D012486:Salmonella typhimurium / Q000187:drug effects; D014018:Tissue Distribution; D014026:Nicotiana / Q000032:analysis
D002273:Carcinogens; D009602:Nitrosamines; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone